BIOMERICA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-05-31 was -16.63K shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-05-31 was 0.00 shares, a 100.00% decline year-over-year.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-02-28 was 0.00 shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-05-31 was 16.00K shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 2.38K shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 46.50K shares, a 17.72% increase from fiscal 2022.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 39.50K shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 34.75K shares, a 89.82% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-05-31 | -16.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | 2.38K shares 10-K · filed 2026-08-31 |
| 2023-05-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | 46.50K shares 10-K · filed 2024-08-28 |
| 2023-02-28 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-14 | |
| 2022-05-31 | 16.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25 | 39.50K shares 10-K · filed 2023-08-25 |
| 2019-02-28 | 11.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-15 | 120.13K shares derived: sum of 4 quarters · filed 2019-04-15 |
| 2018-11-30 | 77.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-14 | 114.88K shares derived: sum of 4 quarters · filed 2019-01-14 |
| 2018-08-31 | 21.50K shares 10-Q · filed 2018-10-15 | 55.25K shares derived: sum of 4 quarters · filed 2018-10-15 |
| 2018-05-31 | 10.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-29 | 34.75K shares 10-K · filed 2018-08-29 |
| 2018-02-28 | 5.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-16 | 30.13K shares derived: sum of 4 quarters · filed 2018-08-29 |
| 2017-11-30 | 17.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-17 | 229.00K shares derived: sum of 4 quarters · filed 2018-08-29 |
| 2017-08-31 | 1.00K shares 10-Q · filed 2017-10-16 | |
| 2017-05-31 | 6.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-29 | 341.50K shares 10-K · filed 2018-08-29 |
| 2017-02-28 | 204.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-14 | |
| 2016-05-31 | 177.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-29 | 269.63K shares 10-K · filed 2017-08-29 |
| 2016-02-29 | 69.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-14 | 104.63K shares derived: sum of 4 quarters · filed 2016-08-29 |
| 2015-11-30 | 5.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-14 | 37.52K shares derived: sum of 4 quarters · filed 2016-08-29 |
| 2015-08-31 | 17.77K shares 10-Q · filed 2015-10-15 | 32.52K shares derived: sum of 4 quarters · filed 2016-08-29 |
| 2015-05-31 | 12.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | 23.00K shares 10-K · filed 2016-08-29 |
| 2015-02-28 | 2.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-14 | 41.00K shares derived: sum of 4 quarters · filed 2015-08-31 |
| 2014-11-30 | 750.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-14 | 73.50K shares derived: sum of 4 quarters · filed 2015-08-31 |
| 2014-08-31 | 8.25K shares 10-Q · filed 2014-10-15 | 75.25K shares derived: sum of 4 quarters · filed 2015-08-31 |
| 2014-05-31 | 30.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | 69.00K shares 10-K · filed 2015-08-31 |
| 2014-02-28 | 34.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-14 | |
| 2013-11-30 | 2.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-14 | |
| 2013-08-31 | 2.00K shares 10-Q · filed 2013-10-15 | |
| 2013-05-31 | 122.38K shares 10-K · filed 2013-08-29 | |
| 2012-05-31 | 84.00K shares 10-K · filed 2013-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |